VNUS Medical Technologies, Inc. Announces the Hiring of Don Todd as Vice President of Marketing

Saturday, April 19, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN JOSE, Calif., April 18 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices forthe minimally invasive treatment of venous reflux disease, today announced thehiring of Don Todd as Vice President of Marketing. He will join the companyon May 5, 2008.

Mr. Todd joins VNUS with over 20 years of marketing experience. Mostrecently Mr. Todd was Sr. Vice President of Marketing at Iridex Corporation,an ophthalmic and aesthetic laser company. Prior to that, he was VicePresident of Sales and Marketing for Cardiac Surgery at Sorin Group NorthAmerica and Executive Vice President of Venetec International. Mr. Todd hasheld increasingly responsible positions in sales and marketing at TerumoMedical Corporation, Iolab Corporation and CooperVision/Alcon. Mr. Todd holdsa BA Business Administration from Colorado State University.

VNUS President & Chief Executive Officer Brian Farley stated, "We are verypleased that Don Todd has chosen to join VNUS. Don brings a tremendous amountof senior leadership and experience to our company with his priorresponsibilities in marketing, sales and general management in the medicaldevice field."

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasivetreatment of venous reflux disease, a progressive condition that is often theunderlying cause of painful varicose veins. VNUS sells the Closure(R) system,which consists of a proprietary radiofrequency (RF) generator and proprietarydisposable endovenous catheters and devices to close diseased veins throughthe application of temperature-controlled RF energy. Approximately 300,000patients have been treated to date with VNUS Closure catheters. For moreinformation, please visit the corporation website at http://www.vnus.com.

SOURCE VNUS Medical Technologies, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook